RxDoctor Payments Data

Elizabeth Piccolo

Psychiatric/Mental Health · New City, NYNPI 1184862302

Payments from drug & device makers

$1,103in general payments, 2019–2025

Across 27 payments — averaging $40.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Idorsia Pharmaceuticals US Inc$246
  • Otsuka America Pharmaceutical, Inc.$229
  • Corium, LLC$199
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$162
  • Neurocrine Biosciences, Inc.$116
  • Ironshore Pharmaceuticals Inc.$95
  • plus $56 from 2 others

What the payments were for

  • Food & beverage$1,103100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,103 in reported general payments places this provider in the 65th percentile of 2,385 psychiatric/mental health providers in New York.

See all psychiatric/mental health providers in New York

Medicare billing

Part B allowed, 2024
$102,698
Medicare patients
86
Services billed
948

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Aripiprazole16$4,063
Methylphenidate ErMethylphenidate Hcl22$2,781
Duloxetine Hcl90$2,534
Bupropion XlBupropion Hcl41$1,321
Sertraline Hcl95$1,093
Divalproex Sodium36$1,061
Quetiapine Fumarate32$608
Fluoxetine Hcl27$513
Escitalopram Oxalate35$442
Divalproex Sodium ErDivalproex Sodium25$441
Mirtazapine26$412
Risperidone44$410
Venlafaxine Hcl ErVenlafaxine Hcl11$347
Lamotrigine34$247
Gabapentin15$167

Paid to pharmacies, not to this prescriber.

Other psychiatric/mental health in New City

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →